study,id,treatment,stroke,total
AFASAK-I 1989,1,VKAs,9,335
AFASAK-I 1989,1,Aspirin,16,336
AFASAK-I 1989,1,Placebo/Control,19,336
BAATAF 1990,2,VKAs,3,212
BAATAF 1990,2,Placebo/Control,13,208
CAFA 1991,3,VKAs,6,187
CAFA 1991,3,Placebo/Control,9,191
SPAF-I 1991,4,VKAs,8,210
SPAF-I 1991,4,Aspirin,24,552
SPAF-I 1991,4,Placebo/Control,42,568
SPINAF 1992,5,VKAs,7,260
SPINAF 1992,5,Placebo/Control,23,265
EAFT 1993,6,VKAs,20,225
EAFT 1993,6,Aspirin,88,404
EAFT 1993,6,Placebo/Control,90,378
SPAF-II 1994,7,VKAs,39,555
SPAF-II 1994,7,Aspirin,42,545
AFASAK-II 1998,8,VKAs,10,170
AFASAK-II 1998,8,Aspirin,9,169
PATAF 1999,9,VKAs,3,131
PATAF 1999,9,Aspirin,22,319
LASAF 1999,10,Aspirin,5,194
LASAF 1999,10,Placebo/Control,3,91
ACTIVE (W) 2006,11,VKAs,59,3371
ACTIVE (W) 2006,11,Aspirin+Clopidogtrel,100,3335
JAST 2006,12,Aspirin,17,426
JAST 2006,12,Placebo/Control,18,445
ACTIVE (A) 2006,13,Aspirin+Clopidogtrel,296,3772
ACTIVE (A) 2006,13,Aspirin,408,3782
Chinese/ATAFS 2006,14,VKAs,9,335
Chinese/ATAFS 2006,14,Aspirin,17,369
BAFTA 2007,15,VKAs,21,488
BAFTA 2007,15,Aspirin,44,485
RE-LY 2009,16,Dabigatran 110mg,171,6015
RE-LY 2009,16,Dabigatran 150mg,122,6076
RE-LY 2009,16,VKAs,185,6022
ROCKET 2011,17,Rivaroxaban,188,7081
ROCKET 2011,17,VKAs,240,7090
ARISTOTLE 2011,18,Apixaban,197,9120
ARISTOTLE 2011,18,VKAs,248,9081
AVERROES 2011,19,Apixaban,49,2808
AVERROES 2011,19,Aspirin,105,2791
"WASPO, 2007",20,VKAs,0,36
"WASPO, 2007",20,Aspirin,0,39
